T1	Outcomes 77 120	non-resectable colorectal liver metastases]
T2	Outcomes 127 144	relative efficacy
T3	Outcomes 324 337	response rate
T4	Outcomes 451 484	survival and time to progression.
T5	Outcomes 508 516	inferior
